Curative Biotechnology (CUBT) Short Interest Ratio & Short Volume → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free CUBT Stock Alerts $0.03 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Curative Biotechnology Short Interest DataCurrent Short Volume1,200 sharesPrevious Short Volume29,000 sharesChange Vs. Previous Month-95.86%Dollar Volume Sold Short$34.80Short Interest Ratio / Days to Cover0.0Last Record DateMarch 15, 2024Outstanding Shares703,263,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume61,501 sharesAverage Trading Volume239,091 sharesToday's Volume Vs. Average26% Short Selling Curative Biotechnology ? Sign up to receive the latest short interest report for Curative Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCUBT Short Interest Over TimeCUBT Days to Cover Over TimeCUBT Percentage of Float Shorted Over Time Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. Curative Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20241,200 shares $34.80 -95.9%N/A0 $0.03 2/29/202429,000 shares $957.00 -83.3%N/A0 $0.03 2/15/2024173,600 shares $5,642.00 +3,238.5%N/A0.4 $0.03 1/15/202485,700 shares $2,373.89 +1,013.0%N/A0.1 $0.03 12/31/20237,700 shares $164.01 -26.0%N/A0 $0.02 12/15/202310,400 shares $183.04 +333.3%N/A0 $0.02 Get the Latest News and Ratings for CUBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11/30/20232,400 shares $26.64 -83.2%N/A0 $0.01 11/15/202314,300 shares $171.60 +31.2%N/A0 $0.01 10/31/202310,900 shares $104.64 +165.9%N/A0 $0.01 10/15/20234,100 shares $44.69 No ChangeN/A0 $0.01 8/31/202351,800 shares $709.66 -95.1%N/A0.1 $0.01 8/15/20231,064,000 shares $17,024.00 -59.9%N/A1.8 $0.02 7/31/20232,653,100 shares $41,123.05 -32.4%N/A3.7 $0.02 7/15/20233,925,800 shares $67,720.05 +0.8%N/A6.6 $0.02 6/30/20233,896,400 shares $70,135.20 +1.1%N/A3 $0.02 6/15/20233,852,300 shares $55,858.35 -1.2%N/A5.1 $0.01 5/31/20233,897,300 shares $51,834.09 +0.2%N/A3 $0.01 5/15/20233,889,900 shares $66,517.29 +1.0%N/A6.2 $0.02 4/30/20233,852,300 shares $70,497.09 No ChangeN/A8.7 $0.02 4/15/20233,852,300 shares $68,956.17 No ChangeN/A14.1 $0.02 3/31/20233,852,300 shares $87,061.98 -1.3%N/A7.2 $0.02 3/15/20233,901,500 shares $73,348.20 +0.7%N/A17.9 $0.02 2/28/20233,875,900 shares $89,145.70 +0.6%N/A9.3 $0.02 2/15/20233,852,300 shares $96,307.50 -0.7%N/A13.9 $0.03 1/31/20233,880,600 shares $116,029.94 +2.2%N/A3.2 $0.03 1/15/20233,796,100 shares $94,902.50 +18.6%N/A3.5 $0.03 12/30/20223,199,600 shares $63,992.00 No ChangeN/A3.4 $0.02 12/15/20223,199,600 shares $46,394.20 +54.6%N/A4.1 $0.01 11/30/20222,070,300 shares $37,265.40 +0.7%N/A2.5 $0.02 11/15/20222,057,000 shares $41,140.00 -36.0%N/A2.8 $0.02 10/31/20223,215,300 shares $64,306.00 +32,053.0%N/A7 $0.02 10/15/202210,000 shares $190.00 +222.6%N/A0 $0.02 9/30/20223,100 shares $49.29 -77.9%N/A0 $0.02 9/15/202214,000 shares $392.00 +102.9%N/A0 $0.03 8/31/20226,900 shares $204.24 No ChangeN/A0 $0.03 7/31/202223,400 shares $723.06 +42.7%N/A0 $0.03 7/15/202216,400 shares $539.56 -67.2%N/A0 $0.03 6/30/202250,000 shares $1,530.00 No ChangeN/A0 $0.03 5/31/202224,100 shares $843.50 +62.8%N/A0.1 $0.04 5/15/202214,800 shares $611.24 -49.0%N/A0 $0.04Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… CUBT Short Interest - Frequently Asked Questions What is Curative Biotechnology's current short interest? Short interest is the volume of Curative Biotechnology shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 1,200 shares of CUBT short. Learn More on Curative Biotechnology's current short interest. Is Curative Biotechnology's short interest increasing or decreasing? Curative Biotechnology saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 1,200 shares, a drop of 95.9% from the previous total of 29,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Curative Biotechnology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Curative Biotechnology: Pacific Health Care Organization, Inc. (0.00%), BioRestorative Therapies, Inc. (0.58%), Ontrak, Inc. (0.96%), Cryo-Cell International, Inc. (0.65%), CareCloud, Inc. (1.59%), Meihua International Medical Technologies Co., Ltd. (0.83%), bioAffinity Technologies, Inc. (1.77%), Talphera, Inc. (0.61%), NeuroSense Therapeutics Ltd. (0.38%), NuCana plc (5.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Curative Biotechnology stock? Short selling CUBT is an investing strategy that aims to generate trading profit from Curative Biotechnology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Curative Biotechnology? A short squeeze for Curative Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CUBT, which in turn drives the price of the stock up even further. How often is Curative Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUBT, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OTRK Short Interest PFHO Short Interest BRTX Short Interest CCEL Short Interest PMCB Short Interest ITRM Short Interest NRBO Short Interest BIVI Short Interest CVALF Short Interest BFRG Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CUBT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets